MedPath

Med-Life Discoveries LP

Med-Life Discoveries LP logo
🇨🇦Canada
Ownership
Holding
Established
2015-01-01
Employees
1
Market Cap
-
Website
http://www.med-life.ca

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 1:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials

Phase 1
1 (100.0%)

A First-in-Human Phase 1 Study of Plasmalogen Precursor PPI-1011 in Healthy Adult Volunteers to Assess Safety, Tolerability, and Pharmacokinetics

Phase 1
Recruiting
Conditions
Rhizomelic Chondrodysplasia Punctata
Interventions
Drug: Placebo
First Posted Date
2023-08-01
Last Posted Date
2023-08-01
Lead Sponsor
MED-LIFE DISCOVERIES LP
Target Recruit Count
56
Registration Number
NCT05969977
Locations
🇨🇦

Biopharma Services Inc., Toronto, Ontario, Canada

RCDP Natural History Study

Conditions
Rhizomelic Chondrodysplasia Punctata
First Posted Date
2019-07-24
Last Posted Date
2019-08-02
Lead Sponsor
MED-LIFE DISCOVERIES LP
Target Recruit Count
75
Registration Number
NCT04031287
Locations
🇺🇸

Alfred I. DuPont Hospital for Children, Wilmington, Delaware, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.